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Full-length porcine growth hormone (PGH) cDNA clones were isolated from a porcine pituitary cDNA 
library. When the coding portion of the PGH gene was cloned into an E. coli expression vector downstream 
from the powerful trc promoter, high levels of mRNA, but no protein were detected. Mutation directed 
by an oligodeoxynucleotide primer altered 5’-non-coding sequences and raised the level of PGH produced 
from undetectable to 15% of the total cellular protein. Alteration of four codons infrequently used by E. coli 
in the 5’-end of the gene produced no further increases. 
Translational efficiency; Oligonucleotide-directed mutagenesis; Ribosome binding site; Codon alteration; Growth 
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1. INTRODUCTION 
A number of recent papers have described dif- 
ficulty in obtaining high levels of eukaryotic pro- 
tein expression in E. coli, despite the presence of 
high levels of mRNA produced from powerful pro- 
moters, such ash PL [ 1,2]. The low level of protein 
results from inefficient translation as alterations 
which yield increased levels of protein do not alter 
mRNA levels [l]. The most common way produc- 
tion increases are engineered is by synthesizing (or 
mutating) the 5 ‘-coding region of the gene, incor- 
porating codons that either (i) mimic those 
translated with high efficiency by E. cofi [ 1,3,4] or 
(ii) inhibit the formation of secondary structures in 
the RNA [2,5]. 
This paper describes a mutation, 5’ to the 
coding region, which increased the production of 
porcine growth hormone (PGH) in E. coli by 
greater than lOO-fold. Alteration of codons infre- 
quently used by E. coli in the 5’-end of the gene to 
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those used in highly expressed E. coli proteins, 
produced no significant increase in levels in con- 
structs with either the altered or normal 
5 ’ -flanking sequences. The 5 ’ -non-coding altera- 
tion was carried out using a single oligodeox- 
ynucleotide primer and was thus considerably 
quicker and easier than codon replacement by par- 
tial gene synthesis or extensive mutagenesis, which 
in itself may not overcome translational problems 
VI. 
2. MATERIALS AND METHODS 
2.1. Oligodeoxynucleotides 
All oligodeoxynucleotides and linkers were syn- 
thesized by Biotechnology Research Enterprises 
SA (BRESA). The oligonucleotide sequences were 
as follows: GH.25, 5 ’ -dCAGCCAGTTGGTGCA- 
GGTGCTGGGC-3 ’ ; GH.27, 5 ’ -dGCCATCTTC- 
CAGCTCCCGCATCAGGGC-3 ’ ; GH.30,5 ’ -dG- 
GGCATGGCTGGGAACATGGTCTGTTTCCT- 
3 ’ ; GH.38, 5 ’ -dCATGGCTGGGAACATATAT- 
TACCTCCTGTGTGAAATTG-3 ’ ; GH.34, 5 ’ - 
dCGGCGTTGGCGAACAGGCTGGACAGCG- 
GCATGGC-3 ’ . 
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2.2. cDNA cloning 
Poly(A)+ RNA was isolated from porcine 
pituitaries by the method described in [6] and two 
rounds of enrichment through an oligo-dT col- 
umn. The RNA was then converted to cDNA by 
the RNase H method [7] and cloned into pUC19 
[8] after the addition of synthetic EcoRI linkers. 
Colonies containing PGH sequences were iden- 
tified by colony hybridization as described [9]. The 
hybridization probe used was a 27 base synthetic 
oligodeoxynucleotide (GH.27) which is com- 
plementary to PGH mRNA [3]. One positive, 
pPG.3, had an insert of 820 bp which was com- 
pletely sequenced [IO] after subcloning a number 
of restriction fragments into Ml3 mp18 and mp19 
vectors. 
The insert of this plasmid contained a full-length 
cDNA consisting of a 5 ‘-untranslated region of 
41 bp, a coding region of 648 bp and a 
3 ‘-untranslated region of 105 bp ending with a 
14 bp poly(A) tail. The open reading frame codes 
for a 216 amino acid prehormone, identical to the 
partial length PGH amino acid sequence deduced 
by Seeburg et al. [3]. The sequence missing from 
the cDNA clone of Seeburg et al. [3] is illustrated 
in fig.1 (clone pKTGH). 
3. RESULTS 
To obtain expression of PGH in E. coli a P&I 
fragment was isolated from the replicative form 
(RF) of the Ml3 phage containing the EcoRI insert 
from pPG.3 and cloned into pKT52, a high copy 
number expression vector, kindly provided by J. 
Shine, containing the powerful trc promoter [ 111, 
regenerating the full sequence of the pre-hormone 
(fig.1). Following transformation into a lac I4 host 
such as JMlOl, cells containing this plasmid, 
pKTGH, should produce pre-PGH when induced 
with IPTG. However, no additional protein was 
visible when extracts from such cells were elec- 
trophoresed on SDS-PAGE [12] and stained with 
Coomassie blue. As our primary aim was to obtain 
expression of the mature form of PGH, this lack 
of expression was not pursued. 
Oligodeoxynucleotide-directed mutagenesis was 
used to remove the sequences coding for the ‘pre’ 
region of the hormone. An EcoRI fragment con- 
taining the trc promoter fused to the PGH cDNA, 
was isolated from pKTGH and cloned into mp19. 
Single-stranded DNA isolated from this phage was 
then used in mutagenesis reactions. To remove the 
75 bp coding for amino acids 2-26 a 30 base 
oligodeoxynucleotide, GH.30, complementary to 
15 bases either side of the required deletion was us- 
ed. Following mutagenesis [13] the reaction mix- 
ture was transformed into JMlOl and phage 
containing the required deletion were identified by 
plaque hybridization, followed by nucleotide se- 
quencing using the PGH-specific 25 base 
oligodeoxynucleotide, GH.25 as primer. RF DNA 
was isolated from one of the phage containing the 
RBS 
+24 - 
pKTGH . ..CACAGGAAACAGACC 
pCHX.1 . ..CACAGG~CAGA~C 
pGHXS.4 . ..CACAGGAGGTAATAT 
pGHXC.1 . ..CACAGG~CAGA~C 
pGHXSC.4 . ..CACAGGAGGTAATAT 
ATG GCT GCA GGC CCT CGG ACC TCC GTG CTC CTG... 
met ala ala gly pro arg thr ser val leu leu 
ATG TTC CCA GCC ATG CCC TTG TCC AGC CTA TTT... 
met phe pro ala met pro leu ser ser leu phe 
ATG TTC CCA GCC ATG CCC TTG TCC AGC CTA TTT... 
met phe pro ala met pro leu ser ser leu phe 
ATG TTC CCA GCC ATG CCG CTG TCC AGC CTG TTC... 
met phe pro ala met przieu ser ser leii phz 
ATG TTC CCA GCC ATG CCG CTG TCC AGC CTG TTC... 
met phe pro ala met pro ieu ser ser le< phg 
Fig.1. Nucleotide sequence of construct RBS/spacer regions. Spacer and codon alterations have been underlined. 
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correct deletion and the EcoRI insert purified and 
subcloned back into the larger EcoRI fragment of 
pKTGH. The modified nucleotide sequence of this 
clone, pGHX.1, is shown in fig.1. When extracts 
from induced cells containing this plasmid were 
analysed by SDS-PAGE, no additional protein of 
the expected Mr corresponding to methionyl-PGH 
(m-PGH, Mr 22000) was detected. A number of 
reports have indicated that sequences between the 
RBS and the initiator ATG, hereafter called the 
‘spacer’, can influence translation efficiency 
[4,14-171. We therefore decided to alter the se- 
quence outside the coding area around the RBS, as 
the sequence of pKT52 is far from the consensus 
sequence in this region (see above references). 
A 38 base oligodeoxynucleotide (GH.38) was 
designed to alter the RBS from AGGAAA to a 
consensus AGGAGG and the spacer from 
CAGACC to TAATAT, as a number of reports 
have indicated that AT-rich spacers can increase 
protein expression [4,15]. Single-stranded DNA 
containing the small pGHX. 1 EcoRI fragment was 
mutagenized as described above and positive 
plaques selected and sequenced. RF DNA was 
prepared from phage containing the correct muta- 
tion and cloned back into pKTGH. The nucleotide 
sequence of the altered RBS/spacer of this plasmid 
is shown in fig.1. Extracts prepared from cells 
transformed with this plasmid, pGHXS.4, con- 
tained high levels of m-PGH (fig.2), indicating 
that the translational problem had been overcome. 
In addition to the RBS/spacer alteration, we in- 
vestigated the effects of strategic 5 ’ -codon altera- 
tion on PGH translation. A 34 base oligodeoxy- 
nucleotide (GH.34) complementary to bases 
134- 168 of the PGH gene, but with 4 base changes 
which would alter codons 6, 7, 10 and 11 of 
m-PGH to those favoured by E. cofi, was utilized 
(fig.1). Both Ml3 clones with the original RBS/ 
spacer and the altered spacer of pGHXS.4 were 
mutagenized and mutants selected, screened 
and sequenced as described above (see fig.1). The 
levels of PGH produced by pKTGH (pre-PGH), 
pGHX. 1 (m-PGH), pGHXS.4 (RBS/spacer 
altered m-PGH) and codon altered forms of the 
latter two plasmids are illustrated in fig.2. The 
percentage of total cellular protein expressed as 
PGH was determined by laser densitometry and 
ranged from less than 0.1% for plasmids pKTGH 
and pGHX.1, to approx. 15% for plasmid 
pGHXS.4. 
Fig.2. PGH protein production levels. JMlOl cells 
containing expression plasmids were induced with 
IPTG, then lysed and subjected to SDS-PAGE [12]. 
The observed increase in PGH production was 
due to the enhancement of translational efficiency, 
as PGH mRNA levels were found to be similar in 
cells containing each of the different plasmids (not 
shown). 
4. DISCUSSION 
Our results indicate that the alteration of the 
RBS/spacer region was all that was required to 
enhance the translation of PGH mRNA in E. coli. 
The protocol followed differs significantly from 
those previously used which usually rely on either 
a number of random changes [2] or the systematic 
alteration of codons [3]. PGH has also been ex- 
pressed in E. coli by Seeburg et al. [3] who ob- 
tained high level expression by replacing the entire 
5 ‘-end of the PGH cDNA with a synthetic DNA 
sequence incorporating codons known to be effi- 
ciently expressed. This approach is by no means 
generally applicable and relies on the nucleotide se- 
quence of the specific promoter/spacer chosen not 
interacting with the coding region of the gene [2]. 
The alteration of the RBS/spacer region to a se- 
quence which efficiently interacts with the E. cofi 
16 S rRNA and is AT rich and thereby less likely 
to interact with coding sequences in a deleterious 
manner is therefore a useful alternative. The use of 
a redundant mutagenesis oligodeoxynucleotide 
could supplement he approach described in this 
157 
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paper and increase the probability of generating an 
RBS/spacer sequence which allows efficient 
translational initiation. 
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